Alopecia Totalis (AT): Clinical Trials

4 trials for Alopecia Totalis (AT), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 42Not yet recruiting 1, Recruiting 1

Follow Alopecia Totalis (AT): new trials by email Literature Review of Alopecia Totalis (AT) trials Research Report on Alopecia Totalis (AT)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)
Tofacitinib, Methotrexate - Alopecia Areata, Alopecia Totalis (AT)
Phase 4Not yet recruitingHayat Abad Medical Complex, Peshawar782026-02-152026-02-12
Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study
Methotrexate, Cyclosporin (CSA) - Alopecia Areata(AA), Alopecia Areata (AA)
Phase 4RecruitingErasmus Medical Center502025-11-012026-02-02
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Vehicle, ATI-50002 - Alopecia Universalis (AU), Alopecia Totalis (AT)
Phase 2CompletedAclaris Therapeutics, Inc.112017-12-142020-07-02
Tofacitnib for the Treatment of Alopecia Areata and Variants
Tofacitinib Administration - Alopecia Areata (AA), Alopecia Totalis (AT)
Phase 2CompletedYale University302014-07-012017-04-04

Narrower conditions

Alopecia universalis (4)  ·  Alopecia Areata (3)

Broader conditions

Alopecia (3)  ·  Hair Diseases (3)  ·  Hypotrichosis (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)

Interventions

Methotrexate (2)  ·  Cyclosporine (1)  ·  tofacitinib (1)

Sponsors

Aclaris Therapeutics, Inc. (1)  ·  Erasmus Medical Center (1)  ·  Hayat Abad Medical Complex, Peshawar (1)  ·  Yale University (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Brett King, MD (1)

Results publications

PMID 22512484, PMID 22524397, PMID 24202232, PMID 26183987, PMID 27699252, PMID 28300084, PMID 29273100, PMID 29273101, PMID 29466675, PMID 29723356, PMID 29791718, PMID 30073292, PMID 33376289, PMID 7791384, PMID 8557859